Folvite

Folic Acid Deficiency, Postpartum state, Folic Acid Deficiency + 7 more

Treatment

20 Active Studies for Folvite

What is Folvite

Folic acid

The Generic name of this drug

Treatment Summary

Folic acid, also known as folate or Vitamin B9, is an essential nutrient for the body. It helps with the production of DNA and RNA and is necessary for cell division. As people cannot produce folic acid on their own, it must be obtained from food sources such as green vegetables, beans, avocado, and some fruits. Folic acid is especially important for pregnant women to help prevent neural tube defects in newborns. It can also be supplemented to individuals using certain medications, such as antiepileptic drugs. Insufficient levels of folic acid can lead to cardiovascular disease, anemia, cognitive deficiencies, and

O-Cal FA multivitamin

is the brand name

image of different drug pills on a surface

Folvite Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

O-Cal FA multivitamin

Folic acid

1970

151

Effectiveness

How Folvite Affects Patients

Folic acid, also known as Vitamin B9 or folate, is an important vitamin found in foods like liver, kidney, and leafy green vegetables. It is necessary for the body to build and repair DNA and RNA, as well as to produce proteins. Folic acid is especially important in times of rapid cell division such as infancy, pregnancy, and erythropoiesis, and can help protect against cancer. Humans are not able to produce folic acid on their own, so it needs to be taken from food or supplements. In order for folic acid to work in the body, it is reduced by an enzyme

How Folvite works in the body

Folic acid helps the body in many different ways. To do this, it needs to be converted into active forms like tetrahydrofolic acid and methyltetrahydrofolate. These active forms are then transported into cells and used to synthesize important molecules like purines and thymidylate nucleic acids. Folic acid also helps the body convert homocysteine into methionine, which can help reduce high levels of homocysteine. Vitamin B12 is needed to help folic acid do this.

When to interrupt dosage

The measure of Folvite is contingent upon the diagnosed condition, including Pregnancy, Iron deficiency anemia and Iron deficiency. The measure fluctuates as per the method of delivery featured in the table beneath.

Condition

Dosage

Administration

Postpartum state

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated - Oral, , Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, Capsule, gelatin coated, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Powder, Powder - Oral, Solution / drops - Oral, Injection, powder, lyophilized, for solution - Intravenous, Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Capsule, extended release - Oral, Capsule, extended release, Kit, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intravenous, Solution / drops, Solution, Sublingual, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Pill - Oral, Pill, Granule, effervescent, Tablet, effervescent - Oral, Tablet, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Transdermal, Capsule, coated - Oral, Capsule, coated, Patch, Patch - Transdermal, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection - Intravenous, Injection

Nutritional supplementation

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated - Oral, , Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, Capsule, gelatin coated, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Powder, Powder - Oral, Solution / drops - Oral, Injection, powder, lyophilized, for solution - Intravenous, Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Capsule, extended release - Oral, Capsule, extended release, Kit, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intravenous, Solution / drops, Solution, Sublingual, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Pill - Oral, Pill, Granule, effervescent, Tablet, effervescent - Oral, Tablet, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Transdermal, Capsule, coated - Oral, Capsule, coated, Patch, Patch - Transdermal, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection - Intravenous, Injection

Iron deficiency

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated - Oral, , Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, Capsule, gelatin coated, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Powder, Powder - Oral, Solution / drops - Oral, Injection, powder, lyophilized, for solution - Intravenous, Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Capsule, extended release - Oral, Capsule, extended release, Kit, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intravenous, Solution / drops, Solution, Sublingual, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Pill - Oral, Pill, Granule, effervescent, Tablet, effervescent - Oral, Tablet, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Transdermal, Capsule, coated - Oral, Capsule, coated, Patch, Patch - Transdermal, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection - Intravenous, Injection

Folic Acid Deficiency

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated - Oral, , Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, Capsule, gelatin coated, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Powder, Powder - Oral, Solution / drops - Oral, Injection, powder, lyophilized, for solution - Intravenous, Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Capsule, extended release - Oral, Capsule, extended release, Kit, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intravenous, Solution / drops, Solution, Sublingual, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Pill - Oral, Pill, Granule, effervescent, Tablet, effervescent - Oral, Tablet, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Transdermal, Capsule, coated - Oral, Capsule, coated, Patch, Patch - Transdermal, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection - Intravenous, Injection

methotrexate toxicity

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated - Oral, , Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, Capsule, gelatin coated, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Powder, Powder - Oral, Solution / drops - Oral, Injection, powder, lyophilized, for solution - Intravenous, Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Capsule, extended release - Oral, Capsule, extended release, Kit, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intravenous, Solution / drops, Solution, Sublingual, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Pill - Oral, Pill, Granule, effervescent, Tablet, effervescent - Oral, Tablet, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Transdermal, Capsule, coated - Oral, Capsule, coated, Patch, Patch - Transdermal, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection - Intravenous, Injection

Anemia, Iron-Deficiency

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated - Oral, , Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, Capsule, gelatin coated, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Powder, Powder - Oral, Solution / drops - Oral, Injection, powder, lyophilized, for solution - Intravenous, Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Capsule, extended release - Oral, Capsule, extended release, Kit, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intravenous, Solution / drops, Solution, Sublingual, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Pill - Oral, Pill, Granule, effervescent, Tablet, effervescent - Oral, Tablet, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Transdermal, Capsule, coated - Oral, Capsule, coated, Patch, Patch - Transdermal, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection - Intravenous, Injection

Folic Acid Deficiency

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated - Oral, , Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, Capsule, gelatin coated, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Powder, Powder - Oral, Solution / drops - Oral, Injection, powder, lyophilized, for solution - Intravenous, Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Capsule, extended release - Oral, Capsule, extended release, Kit, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intravenous, Solution / drops, Solution, Sublingual, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Pill - Oral, Pill, Granule, effervescent, Tablet, effervescent - Oral, Tablet, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Transdermal, Capsule, coated - Oral, Capsule, coated, Patch, Patch - Transdermal, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection - Intravenous, Injection

Iron Deficiency Anemia

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated - Oral, , Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, Capsule, gelatin coated, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Powder, Powder - Oral, Solution / drops - Oral, Injection, powder, lyophilized, for solution - Intravenous, Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Capsule, extended release - Oral, Capsule, extended release, Kit, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intravenous, Solution / drops, Solution, Sublingual, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Pill - Oral, Pill, Granule, effervescent, Tablet, effervescent - Oral, Tablet, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Transdermal, Capsule, coated - Oral, Capsule, coated, Patch, Patch - Transdermal, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection - Intravenous, Injection

N-Cadherins

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated - Oral, , Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, Capsule, gelatin coated, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Powder, Powder - Oral, Solution / drops - Oral, Injection, powder, lyophilized, for solution - Intravenous, Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Capsule, extended release - Oral, Capsule, extended release, Kit, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intravenous, Solution / drops, Solution, Sublingual, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Pill - Oral, Pill, Granule, effervescent, Tablet, effervescent - Oral, Tablet, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Transdermal, Capsule, coated - Oral, Capsule, coated, Patch, Patch - Transdermal, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection - Intravenous, Injection

Avitaminosis

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated - Oral, , Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Capsule, Capsule, gelatin coated, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Powder, Powder - Oral, Solution / drops - Oral, Injection, powder, lyophilized, for solution - Intravenous, Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Capsule, extended release - Oral, Capsule, extended release, Kit, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution - Intravenous, Solution / drops, Solution, Sublingual, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Pill - Oral, Pill, Granule, effervescent, Tablet, effervescent - Oral, Tablet, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Transdermal, Capsule, coated - Oral, Capsule, coated, Patch, Patch - Transdermal, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection - Intravenous, Injection

Warnings

There are 20 known major drug interactions with Folvite.

Common Folvite Drug Interactions

Drug Name

Risk Level

Description

5-fluorouridine

Major

The risk or severity of adverse effects can be increased when Folic acid is combined with 5-fluorouridine.

Capecitabine

Major

The risk or severity of adverse effects can be increased when Folic acid is combined with Capecitabine.

Doxifluridine

Major

The risk or severity of adverse effects can be increased when Folic acid is combined with Doxifluridine.

Flucytosine

Major

The risk or severity of adverse effects can be increased when Folic acid is combined with Flucytosine.

Fluorouracil

Major

The risk or severity of adverse effects can be increased when Folic acid is combined with Fluorouracil.

Folvite Toxicity & Overdose Risk

The lowest toxic dose of IPR-MUS in rats is 85mg/kg, IVN-GPG is 120mg/kg, IVN-MUS is 239mg/kg, IVN-RAT is 500mg/kg, and IVN-RBT is 410mg/kg.

Folvite Novel Uses: Which Conditions Have a Clinical Trial Featuring Folvite?

76 active studies are being conducted to assess the potential of Folvite in managing Iron deficiency anemia, Pregnancy and Postpartum states.

Condition

Clinical Trials

Trial Phases

Nutritional supplementation

1 Actively Recruiting

Early Phase 1

Folic Acid Deficiency

0 Actively Recruiting

Postpartum state

16 Actively Recruiting

Phase 4, Not Applicable

N-Cadherins

0 Actively Recruiting

Avitaminosis

0 Actively Recruiting

Anemia, Iron-Deficiency

9 Actively Recruiting

Phase 2, Phase 3, Phase 4, Not Applicable

Folic Acid Deficiency

0 Actively Recruiting

methotrexate toxicity

0 Actively Recruiting

Iron deficiency

16 Actively Recruiting

Phase 3, Phase 2, Not Applicable, Phase 4

Iron Deficiency Anemia

5 Actively Recruiting

Phase 4, Phase 2, Phase 3, Not Applicable

Patient Q&A Section about folvite

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Folvite a vitamin Tablet?

"Folvite is a vitamin that is available both over the counter and by prescription. It is used as a nutritional supplement to prevent Neural Tube Defects and Folic Acid deficiency, and as a treatment for methanol toxicity. Folvite can be used alone or with other medications."

Answered by AI

What is Folvite used for?

"Folic acid supplements are taken to treat or prevent low folate levels, which can lead to anemia. Low folate levels can be caused by conditions such as poor diet, pregnancy, alcoholism, liver disease, and certain stomach/intestinal problems."

Answered by AI

When should Folvite be taken?

"Folvite 5mg Tablet can be taken at any time of day, but it is best to take it at the same time each day to help remember. Take as prescribed by your doctor. Swallow the medicine whole with a glass of water."

Answered by AI

What is the difference between folic acid and Folvite?

"Folate is a natural form of vitamin B9 found in food, while folic acid is a synthetic form. High intake of folic acid can lead to increased blood levels of unmetabolized folic acid."

Answered by AI

Clinical Trials for Folvite

Image of Citruslabs in Las Vegas, United States.

Beef Liver Supplement for Fatigue

18 - 50
All Sexes
Las Vegas, NV

This is a randomized, triple-blind, placebo-controlled clinical trial evaluating the effects of the Ancestral Supplements Grass Fed Beef Liver oral supplement on energy, mood, and mental clarity over 12 weeks. One hundred male and female participants aged 18-50 who report concerns regarding energy levels, mood, and mental clarity will be enrolled and randomized equally into an intervention arm (beef liver supplement) or a placebo arm. Participants will take their assigned product once daily and complete self-reported questionnaires at Baseline, Week 4, Week 8, and Week 12. Blood testing (iron panel) will be conducted at Baseline and Week 12 at a local Quest Diagnostics Clinic. The primary objective is to evaluate the product's effects on energy and mood; the secondary objective is to assess participants' perceptions of the product's effects on energy, mood, and mental clarity, including happiness, anxiety, well-being, brain fog, and concentration.

Waitlist Available
Paid Trial

Citruslabs

Ancestral Supplements, LLC

Image of Bryn Mawr Hospital in Bryn Mawr, United States.

Doula Support for Breastfeeding

18+
Female
Bryn Mawr, PA

Parents of infants in the neonatal intensive care unit (NICU) face unique barriers to long-term breastfeeding and lactation. The physical and emotional demands of having a critically ill or premature newborn combined with the stress, sleep deprivation, and separation inherent to the NICU environment make it difficult for many mothers to sustain breastfeeding and lactation, even when they want to. At the same time, NICU mothers are at elevated risk for post-traumatic stress disorder (PTSD) and poor health-related quality of life, which can further undermine lactation success and overall maternal wellbeing. PeliCaN Multi-Site Breastfeeding tests whether a trained postpartum doula, working directly in the NICU can improve breastfeeding and lactation outcomes and support maternal mental health through 6 months postpartum. Participants are enrolled during their infant's NICU hospitalization to receive either doula support or standard care, depending on the study site condition at the time of enrollment (control vs. intervention). Mothers in the intervention group will receive lactation education and support, and emotional and informational support from a NICU-informed doula for up to 6 months. Mothers in the usual care group receive standard NICU clinical care, including access to NICU lactation consultants, without study doula support. All participants complete surveys at enrollment and at 6 months postpartum covering infant feeding practices, maternal mental health, and demographic characteristics. The study asks two primary questions: (1) Does NICU-informed postpartum doula support improve breastfeeding and lactation rates at 6 months? (2) Does doula support improve health-related quality of life and reduce post-traumatic stress disorder symptoms at 6 months? A subset of intervention participants, NICU staff, and lactation consultants will also participate in qualitative interviews and brief implementation surveys to assess how well the doula program works in practice across participating sites.

Waitlist Available
Has No Placebo

Bryn Mawr Hospital (+10 Sites)

Heather H Burris, MD, MPH

Image of Christiana Hospital in Newark, United States.

Doula Support for Postpartum Care

18+
Female
Newark, DE

Parents of infants admitted to the neonatal intensive care unit (NICU) face unique challenges in caring for their own health after giving birth. The demands of having a critically ill infant often make it difficult or impossible to attend postpartum care appointments, and research shows that NICU mothers are significantly more likely than other new mothers to develop postpartum depression and other health conditions, including hypertensive disorders of pregnancy. However, these conditions frequently go undetected and untreated because standard postpartum care systems are not designed to address the needs of NICU mothers, who often prioritize being present in the NICU over their own needs. The PeliCaN (Postpartum Care in the NICU) Multi-Site trial will test whether trained postpartum doulas supporting mothers directly in the NICU can help close postpartum care gaps. Study doulas will provide emotional support, help mothers monitor their blood pressure, screen for postpartum depression, assist with scheduling and attending postpartum care visits, and connect families to community resources while their infant is in the NICU and after discharge for up to 6 months. The study team will enroll approximately 756 mothers across 13 NICUs in the Metro-Philadelphia area. Participating NICUs will be randomly assigned to groups on a stepped-wedge schedule to begin offering the doula intervention. Mothers enrolled before their site begins the doula intervention will receive standard postpartum care and support; mothers enrolled after their site transitions to the intervention period will receive doula support. All participants will complete surveys at enrollment and at 6 months after birth and will have their medical records reviewed. The study's main goals are to determine whether having a doula in the NICU helps mothers to receive recommended comprehensive postpartum care within the first 12 weeks after birth and will assess whether doula support reduces symptoms of postpartum depression and increases maternal transition to primary adult care by 6 months postpartum. The study will also examine the experience of implementing doulas in the NICU across multiple hospital sites among intervention participants and NICU staff members.

Waitlist Available
Has No Placebo

Christiana Hospital (+13 Sites)

Heather H Burris, MD, MPH

Have you considered Folvite clinical trials?

We made a collection of clinical trials featuring Folvite, we think they might fit your search criteria.
Go to Trials
Image of AdventHealth Orlando in Orlando, United States.

Ferrous Sulfate for Preterm Infants

29 weeks - 33 weeks
All Sexes
Orlando, FL

The goal of this clinical trial is to determine the serum ferritin level and hematocrit level in very preterm infants receiving donor breast milk(DBM) with an early iron supplementation protocol . The main questions it aims to answer are: Does earlier iron supplementation provide increased ferritin levels at 14 and 28 days of life in subjects fed primarily donor breast milk? Iron supplementation will be implemented when the infant achieves 80ml/kg/day of enteral feeds, as contrasted to the current protocol of full feeds (140 to 160ml/kg/day), the latter usually by Day 14 of life. At day of life(DOL) 14 (± 4 days), a blood sample will be obtained for serum ferritin determination. Similarly, a second blood draw would be performed at day of life 28 (± 4 days) or prior to discharge, whichever comes earlier

Recruiting
Has No Placebo

AdventHealth Orlando

Image of University of Florida in Gainesville, United States.

Enhanced Doula Support for Postpartum Depression

15 - 49
Female
Gainesville, FL

This study is a randomized controlled trial comparing two models of doula support for pregnant individuals enrolled in Medicaid: an enhanced doula support model, in which support starts earlier in pregnancy, occurs more frequently, and continues through the first year after birth, versus the standard doula care currently covered by Medicaid in Florida. The study also builds the doula workforce needed to sustain this model of care, training doulas to become eligible to bill Medicaid for their services. The primary goal is to determine whether the enhanced doula model results in significantly lower rates of perinatal depressive and anxiety symptoms compared to standard doula support, while gathering data on real-world implementation. The study also evaluates the effectiveness of Medicaid-covered doula services more broadly, with findings intended to inform state-level policy on Medicaid reimbursement and the extension of doula services into the postpartum period.

Recruiting
Has No Placebo

University of Florida

Have you considered Folvite clinical trials?

We made a collection of clinical trials featuring Folvite, we think they might fit your search criteria.
Go to Trials
Image of PharmaSouth Research in Coral Gables, United States.

Ferric Bepectate for Iron-Deficiency Anemia

18+
All Sexes
Coral Gables, FL

The goal of this clinical trial is to see if a new intravenous iron formulation (Ferric Bepectate IV Injection) can treat adult patients with iron deficiency anemia (IDA) by increasing blood hemoglobin (Hb) as an established formulation (Ferric carboxymaltose). It will also learn about the safety of Ferric Bepectate IV Injection. The main questions it aims to answer are: * Does hemoglobin increase by the same amount 6 weeks after each treatment? * What medical problems do participants have when being treated with the drug? Researchers will compare single dose treatment plans of Ferric Bepectate to double dose treatment plans of both Ferric Bepectate and Ferric carboxymaltose. Participants and researchers will know which drug they are being provided (open-label). Participants will visit the clinic 5 times over 6 weeks for checkups, blood tests and questionaries. The first two visits will be seven days apart and include the two doses of iron treatment.

Phase 3
Waitlist Available

PharmaSouth Research (+6 Sites)

Ioana Stanescu, Phil.Lic., MSc.

AFT Pharmaceuticals, Ltd.

Image of Carroll University Center for Graduate Studies in Waukesha, United States.

Exercise for Postpartum Recovery

18+
Female
Waukesha, WI

The postpartum period is associated with decreases in physical activity levels, muscular strength, muscular endurance, and pelvic floor muscle function, but little scientific evidence exists on how best to initiate and progress exercise in the postpartum period. This proposal aims to improve habitual physical activity levels, neuromuscular health (i.e., strength, fatigability, symptom burden) and overall wellbeing (i.e., decreased fear of movement, improved sleep quality, improved perception of quality of life) through participation in a weekly exercise program. This study will help to inform postpartum exercise recommendations and is novel as it allows participants to incorporate their children into the exercise routine, thus removing a primary barrier to physical activity/exercise.

Recruiting
Has No Placebo

Carroll University Center for Graduate Studies

Rita Deering, DPT, PhD

Have you considered Folvite clinical trials?

We made a collection of clinical trials featuring Folvite, we think they might fit your search criteria.
Go to Trials